Ubrelvy vs Gabapentin
A side-by-side look at two neurology medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Ubrelvy | US Gabapentin |
|---|---|---|
| Generic name | ubrogepant Unverified catalogue summary (Generic name) for Ubrelvy in US; not checked against current local product information. | gabapentin Unverified catalogue summary (Generic name) for Gabapentin in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Ubrelvy in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Gabapentin in US; not checked against current local product information. |
| Treats | Acute migraine Unverified catalogue summary (Treats) for Ubrelvy in US; not checked against current local product information. | Adult postherpetic neuralgia; partial-onset seizures (add-on, age 3+) Unverified catalogue summary (Treats) for Gabapentin in US; not checked against current local product information. |
| Category | Neurology Unverified catalogue summary (Category) for Ubrelvy in US; not checked against current local product information. | Neurology Unverified catalogue summary (Category) for Gabapentin in US; not checked against current local product information. |
| Manufacturer | AbbVie Inc. (manufactured for) Unverified catalogue summary (Manufacturer) for Ubrelvy in US; not checked against current local product information. | Various (generic) Unverified catalogue summary (Manufacturer) for Gabapentin in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Ubrelvy in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Gabapentin in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Ubrelvy in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Gabapentin in US; not checked against current local product information. |
| Est. TV ad spend | $160M | $1M |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Ubrelvy in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Gabapentin in US; not checked against current local product information. |
Gabapentin
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Ubrelvy or Gabapentin better?
This directory does not compare clinical effectiveness or safety. Listing Ubrelvy and Gabapentin together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Ubrelvy and Gabapentin?
The table shows catalogue identification and estimated advertising information for Ubrelvy and Gabapentin, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Ubrelvy has the larger estimated TV advertising budget of the two.